Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy for Stage I-III Non-small Cell Lung Cancer to an Individualized MLD

NCT00573040 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT00573040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy for Stage I-III Non-small Cell Lung Cancer to an Individualized MLD
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Completed
Start date
August 31, 2005
Completion date
June 30, 2008
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer